These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 16289156)

  • 1. Metallothionein expression in benign and malignant canine mammary gland tumours.
    Erginsoy SD; Sozmen M; Caldin M; Furlanello T
    Res Vet Sci; 2006 Aug; 81(1):46-50. PubMed ID: 16289156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metallothionein expression in canine and feline mammary and melanotic tumours.
    Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
    J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Cox-1 and Cox-2 in canine mammary tumours.
    Queiroga FL; Alves A; Pires I; Lopes C
    J Comp Pathol; 2007; 136(2-3):177-85. PubMed ID: 17416236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-2 expression in canine normal and neoplastic mammary gland.
    Dias Pereira P; Lopes CC; Matos AJ; Santos M; Gärtner F; Medeiros R; Lopes C
    J Comp Pathol; 2009 May; 140(4):247-53. PubMed ID: 19203768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and significance of PTEN in canine mammary gland tumours.
    Qiu C; Lin D; Wang J; Wang L
    Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
    Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
    J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical staining of metallothionein in canine mammary tumors: better survival with higher expression.
    Cardoso SV; Caliari MV; de Aguiar MC; Cassali GD
    Oncol Rep; 2004 Dec; 12(6):1317-21. PubMed ID: 15547757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase reverse transcriptase (TERT) expression in canine mammary tissues: a specific marker for malignancy?
    Zavlaris M; Angelopoulou K; Vlemmas I; Papaioannou N
    Anticancer Res; 2009 Jan; 29(1):319-25. PubMed ID: 19331168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of P-glycoprotein (clone C494) in canine mammary gland tumours.
    Petterino C; Rossetti E; Bertoncello D; Martini M; Zappulli V; Bargelloni L; Castagnaro M
    J Vet Med A Physiol Pathol Clin Med; 2006 May; 53(4):174-8. PubMed ID: 16629950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues.
    Gama A; Gärtner F; Alves A; Schmitt F
    Res Vet Sci; 2009 Dec; 87(3):432-7. PubMed ID: 19464036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and activity of transglutaminase II in spontaneous tumours of dogs and cats.
    Wakshlag JJ; McNeill CJ; Antonyak MA; Boehm JE; Fuji R; Balkman CE; Zgola M; Cerione RA; Page RL
    J Comp Pathol; 2006; 134(2-3):202-10. PubMed ID: 16615935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
    Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
    Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress parameters in bitches with mammary gland tumours.
    Szczubiał M; Kankofer M; Łopuszyński W; Dabrowski R; Lipko J
    J Vet Med A Physiol Pathol Clin Med; 2004; 51(7-8):336-40. PubMed ID: 15533114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical demonstration of metallothionein in benign and malignant canine mammary tumours.
    Fuentealba IC; Mullins JE
    Histol Histopathol; 1999 Jan; 14(1):51-61. PubMed ID: 9987650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD44 in canine mammary tumours.
    Paltian V; Alldinger S; Baumgärtner W; Wohlsein P
    J Comp Pathol; 2009 Nov; 141(4):237-47. PubMed ID: 19592009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAD51 protein expression is increased in canine mammary carcinomas.
    Klopfleisch R; Schütze M; Gruber AD
    Vet Pathol; 2010 Jan; 47(1):98-101. PubMed ID: 20080488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of urokinase plasminogen activator and its prognostic value in canine mammary tumours.
    Santos A; Lopes C; Marques RM; Amorim I; Ribeiro J; Frias C; Vicente C; Gärtner F; de Matos A
    Vet J; 2011 Jul; 189(1):43-8. PubMed ID: 20598596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of VEGF-C expression in canine mammary tumours.
    Qiu C; Lin DD; Wang HH; Qiao CH; Wang J; Zhang T
    Aust Vet J; 2008 Jul; 86(7):279-82. PubMed ID: 18616481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased survival in dogs with malignant mammary tumours overexpressing HER-2 protein and detection of a silent single nucleotide polymorphism in the canine HER-2 gene.
    Hsu WL; Huang HM; Liao JW; Wong ML; Chang SC
    Vet J; 2009 Apr; 180(1):116-23. PubMed ID: 18061495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence.
    Sorenmo KU; Kristiansen VM; Cofone MA; Shofer FS; Breen AM; Langeland M; Mongil CM; Grondahl AM; Teige J; Goldschmidt MH
    Vet Comp Oncol; 2009 Sep; 7(3):162-72. PubMed ID: 19691645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.